← 所有主題

免疫療法與腫瘤學

癌症治療已從毒殺分裂中的細胞,轉向引導免疫系統攻擊腫瘤,以及只將藥物有效成分送達癌變組織的藥物。這個領域吸收的藥物研發支出高於其他任何領域。

388檔股票

# 名稱 持股 交易金額 主題
股票
投資組合
占比
狀態
1
BlackRock
BlackRock
New York
US$2100億 +US$24.3億 203 3.12% 增持
2
Vanguard Capital Management
Vanguard Capital Management
Pennsylvania
US$1551億 +US$6.36億 197 3.31% 增持
3
State Street
State Street
Massachusetts
US$1164億 +US$16.2億 175 3.44% 增持
4
Vanguard Portfolio Management
Vanguard Portfolio Management
Pennsylvania
US$651億 +US$14.8億 114 2.93% 增持
5
Geode Capital Management
Geode Capital Management
Massachusetts
US$588億 +US$6.32億 212 3.14% 增持
6
JP Morgan Chase
JP Morgan Chase
New York
US$540億 -US$84.7億 180 2.99% 減碼
7
Fidelity Investments
Fidelity Investments
Massachusetts
US$538億 -US$5227萬 152 2.33% 減碼
8
Morgan Stanley
Morgan Stanley
New York
US$479億 -US$6.15億 223 2.53% 減碼
9
Evelyn Partners
Evelyn Partners
US$416億 +US$4.96億 13 88.78% 新
10
Norges Bank
Norges Bank
Norway
US$369億 +US$347億 27 3.67% 新
11
Capital World Investors
Capital World Investors
California
US$337億 +US$19.1億 16 3.99% 增持
12
Wellington Management Group
Wellington Management Group
Massachusetts
US$330億 +US$2.61億 83 5.68% 增持
13
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
US$309億 +US$23.9億 117 3.1% 增持
14
Bank of America
Bank of America
North Carolina
US$305億 -US$13億 142 1.97% 減碼
15
Charles Schwab
Charles Schwab
California
US$297億 +US$17.3億 119 3.95% 增持
16
Invesco
Invesco
Georgia
US$277億 -US$5.65億 121 2.19% 減碼
17
Northern Trust
Northern Trust
Illinois
US$266億 -US$3.95億 178 3.09% 減碼
18
Goldman Sachs
Goldman Sachs
New York
US$254億 +US$8.85億 144 2.21% 增持
19
Legal & General Group
Legal & General Group
United Kingdom
US$210億 -US$2.06億 115 4.39% 減碼
20
Fisher Asset Management
Fisher Asset Management
Washington
US$207億 +US$29.1億 33 6.16% 增持
21
Bank of New York Mellon
Bank of New York Mellon
New York
US$204億 -US$2.29億 126 3.35% 減碼
22
Franklin Resources
Franklin Resources
California
US$202億 +US$8.3億 76 4.38% 增持
23
UBS AM
UBS AM
Illinois
US$184億 -US$2.01億 94 3.35% 減碼
24
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
US$171億 +US$8.71億 103 3.1% 增持
25
Capital Research Global Investors
Capital Research Global Investors
California
US$159億 -US$18.1億 9 2.22% 減碼